UAE In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

UAE In-Vitro Diagnostics Market Analysis

The UAE In-Vitro Diagnostics Market size is estimated at USD 108.25 million in 2024, and is expected to reach USD 140.41 million by 2029, growing at a CAGR of 5.18% during the forecast period (2024-2029).

Initially, COVID-19 significantly impacted the in-vitro diagnostics (IVD) market owing to the high demand for these tests for COVID-19 detection. Various market players have launched innovative IVD tests for rapid viral detection. For instance, in February 2021, YAS Pharmaceuticals and Pure Health launched one of the world's first artificial intelligence (AI)-powered rapid COVID-19 antigen tests in the UAE. Through this device, results were delivered within five to eight minutes, with 98.3% specificity in detecting the SARS-CoV-2 virus. Such innovations elevated the demand for IVD in the country during the pandemic. However, the market in the current state has seized since the COVID-19 cases have declined worldwide. The market is expected to show a stable growth rate during the forecast period due to its widespread application in other diseases as well.

The growth of the UAE in vitro diagnostics market is attributed to the high prevalence of chronic and infectious diseases and government initiatives for the management and control of such diseases, which boost the demand for IVD in the country. For instance, according to the UAE government portal 2022 update, 11.8% of the UAE's population were affected by diabetes in 2021. Also, as per the Dubai Health Statistical Yearbook 2021 report, cardiovascular diseases were the most abundant, with a prevalence of 31.1% in Dubai in 2021. Therefore, the high burden of diabetes and cardiovascular diseases in the country is expected to propel the demand for IVD for the diagnosis of diabetes for the better management of such diseases, thereby accelerating market growth.

Furthermore, government initiatives for increasing the screening of diseases utilizing IVD also contribute to the growth of the market. For instance, in January 2023, a new document named 'Sharjah Declaration 3.0' outlining the path for the elimination of cervical cancer was launched during the Cervical Cancer Forum (CCF). The declaration highlighted the importance of collaboration and partnerships between governments, healthcare providers, and civil society organizations, as well as the necessity of increased funding for cervical cancer prevention, screening, and treatment programs. The country's adoption of cancer control initiatives is expected to boost the demand for IVD, such as PCR tests used in laboratories and hospitals to assess cervical cancer in the country, thereby propelling the market growth.

Additionally, the strategic initiatives adopted by market players, such as product launches, approvals, or awards, are also contributing to the market growth. For instance, in December 2022, Roche Diagnostics was one of the first in-vitro diagnostics companies in the Middle East to achieve ISO:27001 Information Security certification, demonstrating its commitment to protecting patient data information and building trust across the region. The expansion of major market players in the country and such achievement is expected to propel the demand for its IVD products, which is ultimately projected to propel the market growth in the forecast period.

Therefore, owing to the aforementioned factors, such as rising government disease control initiatives promoting the usage of IVD and the high concentration of key market players in the country, the studied market is anticipated to witness growth over the analysis period. However, stringent manufacturing and marketing regulations are expected to restrain market growth.

UAE In-Vitro Diagnostics Market Trends

Oncology Segment is Expected to Hold a Significant Growth Over The Forecast Period

UAE In-Vitro Diagnostics Industry Segmentation

As per the scope of the study, in-vitro diagnostics involve medical devices and consumables that are utilized to perform in-vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic and infectious diseases. The UAE in-vitro diagnostics market is segmented by test type (clinical chemistry, immunodiagnostics, molecular diagnostics, hematology, and other test types), product (instrument, reagent, and other products), usability (disposable IVD devices and reusable IVD devices), application (infectious disease, diabetes, oncology, cardiology, autoimmune disease, nephrology, and other applications), and end-user (diagnostic laboratories, hospitals and clinics, and other end users). The report offers the value (in USD) for the above segments.